Newsletter insight
Norwegian Biotech Startup Vitroscope Raises USD 7 Million
Perspectives from the HPC business newsletter.
← All business news
On 3 November, Trondheim-based Vitroscope announced USD 7 million in funding, comprising a USD 5 million seed round co-led by Cerberus Ventures and YZR Capital and USD 2 million in non-dilutive support from the Research Council of Norway. The funding will...
On 3 November, Trondheim-based Vitroscope announced USD 7 million in funding, comprising a USD 5 million seed round co-led by Cerberus Ventures and YZR Capital and USD 2 million in non-dilutive support from the Research Council of Norway. The funding will support commercialisation of its live-tissue research platform and development of a higher-throughput system.
The investment creates opportunities for biotech suppliers, laboratory-equipment providers and life-science partners. HPC can support startup market research, investor materials and funding strategy.